Peritoneal Dialysis

Peritoneal dialysis is a kidney replacement therapy that uses the peritoneal membrane to remove waste and excess fluid through dialysis solution introduced into the abdominal cavity. It can be delivered manually through continuous ambulatory peritoneal dialysis or with an automated cycler, often during sleep. Its relevance is shaped by patient suitability, home-care capacity, catheter services, infection prevention, reimbursement, and the availability of trained clinical support.

The landscape is shifting toward care models that support treatment outside hospitals, where clinically appropriate. This change increases the importance of patient education, caregiver support, reliable supply logistics, remote follow-up, catheter-placement pathways, and rapid management of complications. Health systems are also placing greater emphasis on shared decision-making, earlier modality education, and coordination between nephrology, primary care, surgery, nursing, and community services.

Artificial intelligence can support peritoneal dialysis through risk stratification, pattern recognition in treatment data, adherence support, workflow prioritization, and identification of signals associated with infection, ultrafiltration problems, or technique failure. Effective deployment requires clinically validated data, transparent performance measures, cybersecurity, interoperability, and safeguards against bias. AI should augment nephrologists and dialysis teams rather than replace assessment of symptoms, examination findings, laboratory results, and patient preferences.

In North America, established home-dialysis infrastructure and remote monitoring capabilities support peritoneal dialysis, while affordability, workforce capacity, and equitable access remain important considerations. Latin America faces varied reimbursement, supply-chain, training, and catheter-access conditions across countries. Europe benefits from structured renal services but must address ageing populations, workforce pressures, and differences in national policy. The Middle East is expanding specialized healthcare capacity, with local training and logistics remaining important. Africa requires context-sensitive models that address infrastructure, affordability, water and power reliability, and workforce shortages. Asia-Pacific contains highly diverse systems, ranging from advanced home-care ecosystems to settings where access, family support, urban-rural distance, and supply continuity are decisive.

ASEAN countries must balance rapid urban development with uneven access, workforce distribution, and health-financing capacity. BRICS members encompass substantial variation in public provision, private participation, domestic manufacturing, and regional access. The European Union benefits from cross-border knowledge exchange but retains national differences in reimbursement, procurement, and clinical organization. G7 systems generally have mature nephrology services, yet face cost pressures, ageing populations, and demand for more patient-centered home care. GCC countries can leverage concentrated healthcare investment while strengthening local workforce development and continuity of consumables. NATO members span diverse health systems, making resilience, emergency preparedness, and secure medical supply chains relevant alongside routine dialysis provision.

Australia and Canada have geographically dispersed populations that make home-care support and telehealth valuable. Brazil, Mexico, India, China, and Russia must navigate major regional differences in infrastructure, financing, and specialist access. France, Germany, Italy, Spain, and the United Kingdom have established renal services but continue to address ageing, workforce demands, modality choice, and care integration. Japan and South Korea combine advanced clinical capabilities with demographic ageing and strong expectations for dependable technology and coordinated follow-up. The United States has extensive dialysis infrastructure and growing interest in home modalities, while affordability, training, insurance design, and continuity of care remain central implementation issues.

Leaders should prioritize standardized patient education, early modality counseling, dependable catheter pathways, and structured training for patients and caregivers. They should strengthen infection-prevention programs, establish rapid escalation routes, and use remote monitoring only where connectivity, clinical ownership, and data governance are adequate. Partnerships with public agencies and local providers can improve access in underserved areas, while resilient procurement, inventory planning, technician support, and workforce development can reduce interruptions. Any AI initiative should begin with a clearly defined clinical use case, prospective validation, human oversight, and measurable patient-safety outcomes.

This executive summary uses the defined peritoneal dialysis topic as its scope and synthesizes established clinical and health-system considerations relevant to modality selection and delivery. The analysis organizes findings across six required geographic regions, six economic or political groupings, and fifteen countries. It emphasizes verifiable themes-including home-based care, infection prevention, access, workforce, infrastructure, technology, financing, and resilience-while avoiding unsupported numerical claims, market sizing, forecasts, market shares, and company-specific assertions.

Peritoneal dialysis can support flexible, home-centered kidney care when patients are appropriately selected, trained, and continuously supported. Sustainable implementation depends on coordinated clinical services, equitable financing, dependable supplies, skilled staff, infection control, and responsive follow-up. Regional and national differences make adaptable operating models essential. Leaders that combine patient choice with strong safety systems, resilient infrastructure, and carefully governed digital tools will be better positioned to improve continuity and quality of care.